Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Sweden
  4. Nasdaq Stockholm
  5. Biosergen AB
  6. Summary
    BIOSGN   SE0016013460

BIOSERGEN AB

(BIOSGN)
 SummaryQuotesChartsNewsCompany 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq Stockholm
10/11/2021 10/12/2021 10/13/2021 10/14/2021 10/15/2021 Date
8.62(c) 8.62(c) 8.18(c) 8.5(c) 8.44(c) Last
11 976 12 657 13 644 6 375 9 174 Volume
+1.65% 0.00% -5.10% +3.91% -0.71% Change
More quotes
All news about BIOSERGEN AB
08/31BIOSERGEN : publishes interim report for the second quarter 2021
AQ
08/31Biosergen AB Reports Consolidated Earning Results for the Second Quarter of 2021
CI
08/24BIOSERGEN : Wins Australian Approval To Start Human Trials For Antifungal Drug
MT
08/24BIOSERGEN : application to start human clinical trials with BSG005 is approved
AQ
08/24Biosergen’s Application to Start Human Clinical Trials with BSG005
CI
08/19BIOSERGEN : Tine Kold Olesen will join Biosergen AB as Chief Operating Officer
AQ
08/19Tine Kold Olesen to Join Biosergen AB as Chief Operating Officer, Effective October 1, ..
CI
06/27BIOSERGEN : groundbreaking antifugal drug BSG005 is granted Orphan Drug status in the Unit..
AQ
More news
News in other languages on BIOSERGEN AB

- No features available -

More news
Chart BIOSERGEN AB
Duration : Period :
Biosergen AB Technical Analysis Chart | MarketScreener
Full-screen chart
Managers and Directors
Torsten RŘdiger Goesch Chairman
Lena Birgitta Degling Wikingsson Independent Director
Achim Kaufhold Independent Director
Marianne Kock Independent Director
Henrik Kristian Moltke Independent Director